‌

US Patent 11382968 Coronavirus immunogenic compositions and uses thereof

Patent 11382968 was granted and assigned to Altimmune, Inc. on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Altimmune, Inc.

Current Assignee

Altimmune, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113829680

Patent Inventor Names

Bertrand Victor Gilbert Georges0

M. Scot Roberts0

Date of Patent

July 12, 2022

Patent Application Number

173427690

Date Filed

June 9, 2021

Patent Primary Examiner

‌

Stacy B. Chen

Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11382968 Coronavirus immunogenic compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API